HighTower Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.61M | Sell |
4,481
-739
| -14% | -$226K | ﹤0.01% | 1912 |
|
|
2026
Q1 | $1.31M | Sell |
5,220
-279
| -5% | -$69.4K | ﹤0.01% | 2007 |
|
|
2025
Q4 | $1.51M | Sell |
5,499
-1,070
| -16% | -$293K | ﹤0.01% | 1838 |
|
|
2025
Q3 | $1.72M | Sell |
6,569
-2,249
| -26% | -$547K | ﹤0.01% | 1721 |
|
|
2025
Q2 | $1.93M | Sell |
8,818
-1,369
| -13% | -$293K | ﹤0.01% | 1586 |
|
|
2025
Q1 | $2.28M | Sell |
10,187
-163
| -2% | -$44.9K | ﹤0.01% | 1455 |
|
|
2024
Q4 | $3.39M | Buy |
10,350
+1,812
| +21% | +$570K | ﹤0.01% | 1227 |
|
|
2024
Q3 | $2.58M | Sell |
8,538
-963
| -10% | -$295K | ﹤0.01% | 1361 |
|
|
2024
Q2 | $3.13M | Buy |
9,501
+282
| +3% | +$99.7K | ﹤0.01% | 1214 |
|
|
2024
Q1 | $3.65M | Sell |
9,219
-145
| -2% | -$53.6K | 0.01% | 1109 |
|
|
2023
Q4 | $3.29M | Sell |
9,364
-1,774
| -16% | -$628K | 0.01% | 1169 |
|
|
2023
Q3 | $4.21M | Sell |
11,138
-436
| -4% | -$169K | 0.01% | 1003 |
|
|
2023
Q2 | $4.45M | Buy |
11,574
+59
| +0.5% | +$21.1K | 0.01% | 963 |
|
|
2023
Q1 | $3.98M | Buy |
11,515
+972
| +9% | +$284K | 0.01% | 956 |
|
|
2022
Q4 | $2.48M | Buy |
10,543
+1,057
| +11% | +$250K | 0.01% | 1173 |
|
|
2022
Q3 | $2.31M | Sell |
9,486
-48
| -0.5% | -$14.6K | 0.01% | 1156 |
|
|
2022
Q2 | $2.89M | Sell |
9,534
-1,218
| -11% | -$396K | 0.01% | 1059 |
|
|
2022
Q1 | $4.42M | Sell |
10,752
-4,525
| -30% | -$1.77M | 0.01% | 954 |
|
|
2021
Q4 | $7.17M | Buy |
15,277
+5,453
| +56% | +$2.35M | 0.02% | 734 |
|
|
2021
Q3 | $4.17M | Buy |
9,824
+1,589
| +19% | +$670K | 0.01% | 908 |
|
|
2021
Q2 | $2.96M | Buy |
8,235
+966
| +13% | +$319K | 0.01% | 1022 |
|
|
2021
Q1 | $2.05M | Buy |
+7,269
| New | +$2.08M | 0.01% | 1117 |
|
|
2020
Q4 | – | Sell |
-7,309
| Closed | -$2M | – | 2943 |
|
|
2020
Q3 | $2M | Buy |
7,309
+2,541
| +53% | +$672K | 0.01% | 868 |
|
|
2020
Q2 | $1.07M | Buy |
4,768
+454
| +11% | +$89.2K | 0.01% | 1079 |
|
|
2020
Q1 | $658K | Buy |
4,314
+210
| +5% | +$32.3K | ﹤0.01% | 1204 |
|
|
2019
Q4 | $622K | Sell |
4,104
-1,054
| -20% | -$153K | ﹤0.01% | 1353 |
|
|
2019
Q3 | $729K | Buy |
5,158
+53
| +1% | +$7.3K | ﹤0.01% | 1337 |
|
|
2019
Q2 | $642K | Buy |
5,105
+372
| +8% | +$43.9K | ﹤0.01% | 1396 |
|
|
2019
Q1 | $515K | Buy |
4,733
+444
| +10% | +$46.2K | ﹤0.01% | 1447 |
|
|
2018
Q4 | $423K | Buy |
4,289
+1,489
| +53% | +$162K | ﹤0.01% | 1440 |
|
|
2018
Q3 | $343K | Buy |
+2,800
| New | +$314K | ﹤0.01% | 1662 |
|
Other funds holding WST
GIM
HighTower Advisors's WST Position: Q2 2026 in Review
HighTower Advisors reduced its West Pharmaceutical (WST) stake by 14% in Q2 2026, selling an estimated $226K and leaving 4,481 shares worth $1.61M. The position accounts for ﹤0.01% of the portfolio, ranked #1912.
HighTower Advisors first reported a position in WST in Q3 2018 and has held it in 31 quarters since. The position peaked at $7.17M in Q4 2021. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.
- HighTower Advisors held 4,481 shares of West Pharmaceutical worth $1.61M as of Q2 2026.
- HighTower Advisors sold 739 West Pharmaceutical shares in Q2 2026, an estimated $226K.
- West Pharmaceutical made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #1912 holding.
- HighTower Advisors first reported a position in West Pharmaceutical in Q3 2018 and has held it in 31 quarters since.
- HighTower Advisors's West Pharmaceutical position peaked at $7.17M in Q4 2021.
- 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.
Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.